U.S. Securities and
Exchange Commission Washington, D.C.
20549 Form 10-Q  [x] QUARTERLY REPORT UNDER SECTION 13 OR 15
(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the quarter ended March 31, 2009  [ ]
         TRANSITION REPORT UNDER
SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period
from to Commission File No.
333-123774 Fountain Healthy Aging, Inc. (formerly Immureboost, Inc.) (Name of Registrant in its
Charter)  NEVADA 86-1098668 --------------- -------------------- (State or
Other Jurisdiction of (I.R.S. Employer I.D. No.) incorporation or
organization) 2764 Lake Sahara Drive, Suite 111, Las Vegas, NV 89117 (Address
of Principle Executive Offices)  Registrants
Telephone Number:  (604) 331-1459  Immureboost, Inc. (Former name, former address and former
fiscal year, if changed since last report)  Check whether the registrant  (1) filed all reports
required to be filed by section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the Company was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. (1) Yes
  X       No (2)  Yes  X
      No  Indicate by check mark whether the
registrant has submitted electronically and posted on its corporate Web site, if
any, every Interactive Data File required to be submitted and posted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit
and post such files). Yes  [  ] No
 []  Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company.  See the definitions of large accelerated filer,
accelerated filer, and smaller reporting company, in Rule 12b-2 of the
Exchange Act.  Large
accelerated filer [
 ] Accelerated
filer [
  ] Non-accelerated
filer [
 ] (Do not check if a smaller reporting
company)               
Smaller reporting company [X]   1    Indicate
by check mark whether the registrant is a shell company (as defined in Rule12b-2
of the Exchange Act) Yes    [X]
    No  [  ]  (APPLICABLE ONLY TO CORPORATE ISSUERS)  State the number of shares
outstanding of each of the Issuers classes of common equity, as of the latest
practicable date: May 21, 2009:  Common Stock101,850,000
  shares DOCUMENTS
INCORPORATED BY REFERENCE  A description of any Documents
Incorporated by Reference is contained in Item 6 of this report.    2     Fountain Healthy Aging, Inc. (formerly Immureboost, Inc.) TABLE OF
CONTENTS  PART I.
    FINANCIAL INFORMATION PAGE Item 1.  Financial
Statements (unaudited):  Balance Sheets 5  Statements of Operations 6   Statements of Cash Flows 7   Notes to Financial Statements
(unaudited) 8-10  Item 2.  Managements
Discussion and Analysis of Financial Condition and Results of Operation 11  Item 3.  Quantitative and
Qualitative Disclosures About Market Risk 12  Item 4T. Controls and
Procedures 16  PART II.     OTHER INFORMATION  Item 1.  Legal
Proceedings 16  Item 1A.  Risk Factors  Item 2.  Unregistered
Sales of Equity Securities and Use of Proceeds 16  Item 3.   Defaults
upon Senior Securities 16  Item 4.   Submission
of Matters to a Vote of Securities Holders 16 Item 5.   Other
Information 16 Item 6.
  Exhibits 16 Signatures 16    3    PART
I - FINANCIAL INFORMATION Item
1.   Financial Statements  The
accompanying interim unaudited financial statements of Fountain Healthy Aging,
Inc. (a Nevada corporation) are condensed and, therefore, do not include all
disclosures normally required by accounting principles generally accepted in the
United States of America. These statements should be read in conjunction with
the Company's most recent annual financial statements for the year ended
December 31, 2008, included in a Form10-K filed with the U.S. Securities and
Exchange Commission (SEC) on April 15, 2009. In the opinion of management, all
adjustments necessary for a fair presentation have been included in the
accompanying interim financial statements and consist of only normal recurring
adjustments. The results of operations presented in the accompanying interim
financial statements for the three months ended March 31, 2009, are not
necessarily indicative of the operating results that may be expected for the
full year ending December 31, 2009.  4


FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A
Development Stage Company)  Financial Statements (Unaudited)  For
the Three Months Ended March 31, 2009 and 2008, and
the Period of February 25, 2004 (date of inception) through March 31, 2009  5


FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A Development Stage Company) Balance Sheets  March 31

December 312009

2008(unaudited)AssetsFixed assetsOffice and computer equipment
$
                 4,222

$
                4,222Less accumulated depreciation
(4,211)

(4,199)Net fixed assets
11

23Total assets
$
                      11

$
                     23Liabilities and Stockholders' DeficitCurrent liabilitiesAccounts payable
$
              24,357

$
             18,460Accrued interest, notes payable (Note 6)
8,701

7,267Accrued interest, notes payable  related parties
(Note 6)
374

173Notes payable (Note 6)
64,494

64,494Notes payable  related parties (Notes 2 &
6)
18,950

18,950Note payable  timeshare, current portion (Notes 3
& 6)
-

3,840Total current liabilities
116,876

113,184Long-term liabilitiesNote payable  timeshare, less current portion
(Note 6)
-

17,598Total long-term liabilities
-

17,598Total liabilities
116,876

130,782Stockholders' deficit (Note 4):Common stock; $.001 par value, 1,000,000,000 shares
authorized,101,850,000
 shares issued and outstanding
101,850

101,850Additional paid-in capital
601,356

601,356Deficit accumulated during development stage
(820,071)

(833,965)Total stockholders' deficit
(116,865)

(130,759)Total liabilities and stockholders' deficit
$
                    11

$
               23  See
accompanying notes to financial statements (unaudited).  6    FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A Development Stage Company) Statements of Operations (unaudited)  Quarter Ended March 31,

February 25, 2004 (inception) to
  March  31,2009

2008

2009Revenues
$
                   -

$
                -

$4,000ExpensesGeneral and administrative expenses
5,909

154,609

828,876Impairment of intangible asset (Note 3)
-

-

32,200Total
expenses
5,909

154,609

861,076Net profit (loss)
from operations
(5,909)

(154,609)

(857,076)Other Income (Expenses)Interest expense
(1,635)

(2,615)

(24,897)Gain on timeshare mortgage foreclosure (Notes 3
& 6)
21,438

-

21,438Gain on disposal of assets (Note 3)
-

-

40,464Total
other income (expenses)
19,803

(2,615)

37,005Net profit (loss) and deficit accumulated
during development stage
$
        13,894

$
   (157,224)

$
     (820,071)Net profit (loss) per common share
$
              .00

$
         (.00)Weighted average common shares outstanding , basic
and diluted
101,850,000

101,850,000       See accompanying notes to financial statements (unaudited).  7     FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST,
INC.) (A Development Stage Company) Statements of Cash Flows (unaudited) February 25, 2004(inception) toThree Months ended March 31,

March 31,2009

2008

2009Operating
activitiesNet profit
(loss)
$
             13,894

$
      (157,224)

$
           (820,071)Adjustments to
reconcile net loss to net cashused
in operations:Depreciation
12

12

4,211Gain
on disposal of assets
-

-

(40,464)Stock
issued for services
-

-

500Impairment
of intangible asset
-

-

32,200Gain
on timeshare mortgage foreclosure
(21,438)

-

(21,438)Changes in
operating assets and liabilities:Decrease
in accounts receivable
-

1,069

-Decrease
 in prepaid expense
-

525

-Increase
(decrease)  in accounts payable
5,897

(5,771)

65,722Decrease
in accrued compensation  officer
-

152,777

594,153Increase
in accrued interest  notes payable
1,434

1,292

8,701Decrease
in accrued interest  related parties
201

640

1,227Net cash used
in operating activities
-

(6,680)

(175,259)Investing
activitiesPurchase of
fixed assets
-

-

(4,222)Net cash used
in investing activities
-

-

(4,222)Financing
activitiesIssuance of
common shares for cash
-

-

75,400Proceeds from
notes payable
-

-

65,737Proceeds from
notes payable  related party
-

-

50,950Principal
payments on note payable
-

(580)

(12,606)Net cash
provided by (used in) financing activities
-

(580)

179,481Net decrease in
cash
-

(7,260)

-Cash at
beginning of period
-

7,473

-Cash at end of
period
$
                       -

$
               213

$
                         -Supplemental
disclosures:Interest paid
for in cash
$
                       -

$
               683

$
                11,565Income taxes
paid for in cash
$
                       -

$
                    -

$
                         -Non-cash
investing and financing activities:Purchase of
investment property with note payable
$
                       -

$
                    -

$
                30,104Forgiveness of
debt  related party
$
                       -

$

$
                     300 See accompanying notes to financial statements (unaudited).    8     FOUNTAIN HEALTHY AGING, INC. (formerly
IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three Months Ended March 31, 2009  1. Organization and Summary of
Significant Accounting Policies This summary of significant accounting
policies of FOUNTAIN HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A
development stage company) (the Company) is presented to assist in
understanding the Company's financial statements. These accounting policies
conform to accounting principles generally accepted in the United States of
America and have been consistently applied in the preparation of the
accompanying financial statements. The Company has realized minimal revenues
from its planned principal business purpose and, accordingly, is considered to
be in its development stage in accordance with SFAS No. 7.  The Company has
elected a fiscal year end of December 31. Business
Description FOUNTAIN HEALTHY AGING, INC. is a Nevada corporation
originally organized on February 25, 2004 to acquire timeshares and like
entities and facilitate rentals and sales of the entities and travel packages
via its full-service travel website.    On July 17, 2006, the
Board of Directors voted to change the name of the Company to eSavingStore.com,
Inc.  On June 5, 2007, the Board of Directors voted to change the name of
the Company to Immureboost, Inc.  On August 18, 2007, the Company entered
into an asset purchase agreement with Immureboost Inc., a Thailand company, with
the intention to purchase intellectual property to develop products that affect
the human bodys immune system.  No assets were ever acquired or stock
issued as a result of this agreement, which was declared terminated on or about
August 19, 2008.  On August 27, 2008, the Company changed its name to
Fountain Healthy Ageing, Inc.  On September 16, 2008, the Company changed
the spelling to Fountain Healthy Aging, Inc. The Company has established a
relationship with Natural Planet USA LLC, a California LLC (Natural Planet),
under which the Company had acquired rights to distribute a number of anti-aging
products developed by Natural Planet.  The Company is in the process of
developing its business as a pioneering, science-based company that licenses and
distributes effective, natural, and safe products that slow and delay the aging
process and improve the symptoms associated with aging. Income Taxes The Company recognizes the tax effects of
transactions in the year in which such transactions enter into the determination
of net income, regardless of when reported for tax purposes. Deferred taxes are
provided in the financial statements under SFAS No. 109 to give effect to the
resulting temporary differences which may arise from differences in the bases of
fixed assets, depreciation methods, allowances, and start-up costs based on the
income taxes expected to be payable in future years. Development stage deferred
tax assets approximating $287,000 arising as a result of net operating loss
carryforwards totaling $820,071 have been offset completely by a valuation
allowance due to the uncertainty of their utilization in future periods.
  The valuation allowance decreased by approximately $4,900, and
increased by approximately $55,000 during the three months ended March 31, 2009
and 2008, respectively. Estimates Preparation of financial statements in
accordance with accounting principles generally accepted in the United States of
America requires the use of estimates, such as depreciation and valuation of
timeshare points. Because of the use of estimates inherent in the financial
reporting process, actual results could differ significantly from those
estimates.  Fixed Assets Fixed assets are stated at cost and consist of computers
and other office equipment. Depreciation is computed using the accelerated
double-declining method based on estimated useful lives of 3 years.  Advertising The Company generally expenses advertising costs as
incurred. No advertising costs were incurred during the period of February 25,
2004 (inception) through March 31, 2009.    9    FOUNTAIN
HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three Months Ended March 31, 2009  1. Organization and
Summary of Significant Accounting Policies (continued)  Cash and Cash Equivalents For the purpose of the statements of cash
flows, the Company considers all highly liquid debt instruments purchased with a
maturity of three months or less to be cash equivalents. The Company had $0 in
cash at March 31, 2009 and December 31, 2008.  Revenue Recognition The Company recognizes revenue from the
sale of products and services in accordance with the Securities and Exchange
Commission Staff Accounting Bulletin No. 104 (SAB 104), Revenue
Recognition in Financial Statements.  Revenue will consist of income
from the sale of licenses and products and will be recognized only when all of
the following criteria have been met:  i) Persuasive evidence for an agreement exists; ii) Delivery has occurred; iii) The
fee is fixed or determinable; and iv) Revenue is reasonably assured.  Earnings (Loss) Per Share The computation of net income (loss) per
share of common stock is based on the weighted average number of shares
outstanding during the period presented. There were no potentially dilutive
common share equivalents outstanding during the periods shown and, accordingly,
the computation of net loss per share on a fully dilutive basis is the same as
basic net income (loss) per share.  2.  Related Party Transactions On April 22, 2004, the Company entered into
a consulting agreement with an entity affiliated with its former
president/director. The entity was engaged to perform consulting services and
provide office space for the Company for a term of six months commencing April
22, 2004, in exchange for $15,000. On December 30, 2004, the president/director
resigned from his position with the Company.  For the period of February 25, 2004
(inception) through April 22, 2004 (see above paragraph), and for the period of
July 2006 to the present, office space and services have been provided without
charge by the Company's CEO. Such costs are immaterial to the financial
statements and have not been reflected therein.  In February 2007, the Companys then sole
Officer (the Former Officer) loaned the Company $300 to pay for operating
expenses.  Upon the resignation from his positions with the Company
effective August 28, 2008, the Former Officer forgave the amounts owed to him.
 The Company has written off the debt to additional paid-in capital.  On July 6, 2007, the Company entered into
an employment agreement with the Officer, whereby the Officer would perform
various services for the Company in exchange for annual Officer compensation of
300,000 Euros, plus 100,000 Euros for annual Director's fees.  The
compensation was translated from Euros into US dollars using a weighted average
exchange rate pro-rated for the period of July 2007 through June 2008, resulting
in $156,266 compensation expense for the six months ended June 30, 2008 and
total accrued compensation of $592,873 at June 30, 2008.  The agreement
also entitled the Officer to stock options pursuant to a separate agreement,
which was never executed.  In August 2008, the Officer resigned from his
positions with the Company and released all claims he had against the Company
for debts owed to him. Thus, $592,873 in accrued compensation and $32,000 in
notes payable (plus $2,133 in accrued interest) from 2007 were written off to
additional paid-in capital during the quarter ended September 30, 2008.  In August 2008, a company affiliated with the Companys
CEO advanced the Company $8,400.  In November and December 2008, the
Companys CEO advanced the Company $10,550.  The notes carry an interest
rate of 4.25% and are due on demand (See Note 6).  10    FOUNTAIN
HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three Months Ended March 31, 2009  3.  Intangible Asset and
Note Payable  Timeshare Shortly after
inception, the Company acquired an undivided interest in the Wyndham Vacation
Resorts (formerly Fairfield Resorts, Inc.) (WVR) timeshare resort, along with
the rights to participate in timeshare use, or to allow certain others the use,
of a specified number of days lodging in WVR timeshare properties. The timeshare
interest was being financed by WVR, but the Company defaulted on its payments
during 2008, which compelled WVR to foreclose on the mortgage and revoke the
timeshare interest.  In light of the Companys new business direction, the
Company has been seeking to dispose of the intangible asset.  As a result,
the carrying value of the asset was impaired down to $0 during the fourth
quarter of 2008.   Upon foreclosure, the loan had a carrying value of
$21,438, which has been included in other income on the statement of operations
for the three months ended March 31, 2009. 4.  Stockholders' Equity During March and April 2004, the Company issued common
stock for cash in accordance with separate private offering memorandums as
follows:  Number of
shares Price
per share Cash received 27,000,000 $ .000033 $ 900 28,500,000 .00033 9,500 30,000,000 .001 30,000 11,400,000 .0017 19,000 4,800,000 .0033 16,000 101,700,000 $ 75,400  The Board of Directors authorized a 30:1
forward stock split on July 1, 2006, a 2:1 reverse stock split on June 12, 2008,
and a 2:1 forward stock split on December 22, 2008.  The number of shares
issued in accordance with private offerings in 2004 as listed above has been
retroactively restated to include the effects of the splits.  On October 1, 2006, the Company issued
150,000 shares (post-split) of common stock at $.0033 per share to its transfer
agent for $500 in services, resulting in 101,850,000 common shares issued and
outstanding at March 31, 2009 and December 31, 2008.  Pursuant to a Board of Directors vote, a
Form 8-K was filed with the SEC on July 28, 2006 noting the increase of the
Companys authorized common shares from 75,000,000 to 1,000,000,000 shares.  5.  Going Concern and Liquidity
Considerations The accompanying
financial statements have been prepared assuming that the Company will continue
as a going concern, which contemplates, among other things, the realization of
assets and satisfaction of liabilities in the normal course of business.
 As of March 31, 2009, the Company has a working capital deficit of
$116,876 and an accumulated deficit of $820,071.  Unanticipated costs and
expenses or the inability to generate revenues could require additional
financing, which would be sought through bank borrowings, equity or debt
financing, or asset sales. To the extent financing is not available, the Company
may not be able to, or may be delayed in, developing its services and meeting
its obligations. The Company will
continue to evaluate its projected expenditures relative to its available cash
and to evaluate additional means of financing in order to satisfy its working
capital and other cash requirements. The accompanying financial statements do
not reflect any adjustments that might result from the outcome of these
uncertainties.       11    FOUNTAIN
HEALTHY AGING, INC. (formerly IMMUREBOOST, INC.) (A Development Stage
Company) Notes to Financial Statements
(unaudited) For the Three Months Ended March 31, 2009   6. Notes Payable  Principal balanceMarch 31,

December 31,2009

2008Note Payable Timeshare:Wyndham Vacation Resorts (WVR) (Note 3) for $33,100
 June 2004 inception, June 2014 maturity, $415 monthly payments, 10.99%
annual interest, collateralized by the timeshare property.  Interest
expense of $0 and $683 for the three months ended March 31, 2009 and 2008,
respectively, with no accrued interest at March 31, 2009 or December 31,
2008.  During the current quarter, WVR repossessed the timeshare and
voided the contract.
$
                  -

$
        21,438Notes PayableIndependent investor for $22,994  March 2007
inception, September 2007 maturity, 5.25% annual interest plus 1% interest
per month late fee each month after maturity, unsecured.  Interest
expense of $604 and $992 for the three months ended March 31, 2009 and
2008, respectively.  Accrued interest of $4,929 and $4,326 at March
31, 2009 and December 31, 2008, respectively.
22,994

22,994Independent investor for $15,000  November 2007
inception, due on demand, 8% annual interest, unsecured.  Interest
expense of $301 and $300 for the three months ended March 31, 2009 and
2008, respectively.  Accrued interest of $1,652 and $1,351 at March
31, 2009 and December 31, 2008, respectively.
15,000

15,000Independent investors for $26,500  April 2008, due
on demand, 8% annual interest, unsecured.  Interest expense of $530
and $0 for the three months ended March 31, 2009 and 2008, respectively.
 Accrued interest of $2,120 and $1,590 at March 31, 2009 and December
31, 2008, respectively.
26,500

26,500Total Notes
Payable
64,494

64,494Notes Payable  Related
Parties:Company affiliate  August 2008, due on demand,
4.25% annual interest, unsecured.  Interest expense of $89 for the
three months ended March 31, 2009.  Accrued interest of $226 and $137
at March 31, 2009 and December 31, 2008, respectively.
8,400

8,400Company Officer  November and December 2008, due
on demand, 4.25% annual interest, unsecured.  Interest expense of
$112 for the three months ended March 31, 2009.  Accrued interest of
$148 and $36 at March 31, 2009 and December 31, 2008, respectively.
10,550

10,550Total Notes Payable 
Related Parties
18,950

18,950Total notes payable
83,444

104,882Less current portion
83,444

87,284Total notes payable  long-term
$
                  -

$
        17,598          12


Item 2.
 Managements Discussion and Analysis of Financial Condition and Results of
Operations.  Fountain Healthy Aging, Inc. (formerly Immureboost, Inc.)
was incorporated in the State of Nevada on February 25, 2004.  Since its
inception, the Company has not been involved in any bankruptcy, receivership or
similar proceedings.  It has not undergone any material reclassification,
merger, consolidation, or purchase or sale of a significant amount of assets in
the ordinary course of business.  GENERAL  Prior to August 18, 2007, the Company was in the business
of providing travel bookings and timeshare rentals and sales. Fountain Healthy
Aging, Inc. (formerly Immureboost, Inc) was formed on February 25, 2004, under
the name Celtic Cross, Ltd. as a For Profit corporation for the purpose of
acquiring the timeshare entities discussed herein, and additional like entities
going forward including a full sales and service website.  The Company has
elected a fiscal year end of December 31.  On July 17, 2006, the Board of Directors voted to change
the name of the Company to eSavingStore.com, Inc. to more accurately reflect the
Companys business plan.  On July 5, 2007, the stockholders of the Company
approved the name change to Immureboost, Inc.  On August 27, 2008, the
Company changed its name to Fountain Healthy Aging, Inc.  On August 18,
2007, the Company entered into an Asset Purchase Agreement (Agreement) with
Immureboost of Thailand, a Thai corporation (the "Seller") which develops
processes, products, and pharmaceuticals that interact with the immune system.
Under the terms of the Agreement, the Company would have acquired certain assets
of the Seller, including patents and trademarks. In consideration of these
assets, certain stockholders of the Seller would have received twenty million
three hundred seventy thousand (20,370,000) "restricted shares" (as that term is
defined in Rule 144 of the Securities Act of 1933; the "Act") of the
Company's Common Stock.  No assets were ever acquired or stock issued as a
result of this agreement, which was declared terminated on or about August 19,
2008 The Company has established a
relationship with Natural Planet USA LLC, a California LLC (Natural Planet),
under which the Company had acquired rights to distribute a number of anti-aging
products developed by Natural Planet.  Based upon this, the Company is in
the process of developing its business as a pioneering, science-based company
that licenses and distributes effective, natural, and safe products that slow
and delay the aging process and improve the symptoms associated with aging. In June of 2004, the Company
acquired an undivided interest in the Wyndham Vacation Resorts (formerly
Fairfield Resorts, Inc.) (WVR) timeshare resort, along with the rights to
participate in timeshare use, or to allow certain others the use, of a specified
number of days lodging in WVR timeshare properties. The purchase price of
$33,100 was being financed by WVR at 10.99% annual interest on a ten-year loan.
The maintenance at the WVR facilities are the responsibility of WVR, however,
the Company had previously paid a monthly fee to WVR for this service. The
Company has been unable to maintain the loan and maintenance payments and was
unsuccessful in its attempts to sell this interest.  During the current
quarter, WVR foreclosed on the loan and reclaimed the timeshare interest.  RESULTS OF OPERATIONS The Company has generated $4,000 in revenues since
inception, and has an accumulated deficit of $820,071.  During the three
months ended March 31, 2009 and 2008, we incurred $5,909 and $154,609 in
operating expenses.  The decrease in operating expenses was due to the
departure of Mr. Steven Burke, a former officer with whom the Company had a
compensation arrangement resulting approximately $590,000 in compensation
expense during the term of the arrangement of July 2007 through June 2008.
 At March 31, 2009, we had no current assets and current liabilities of
$116,876, resulting in a working capital deficit of $116,876.  LIQUIDITY. During the next 12 months, the
Company will need significant working capital to fund its research efforts and
meet its current debt obligations. The Company intends to obtain working capital
either from the sale of product or through private investments made by third
parties or debt instruments.


13


Item
3. Quantitative and Qualitative
Disclosures About Market Risk  Not required by smaller reporting companies.  Item 4T. Controls and Procedures  Evaluation of Disclosure Controls and
Procedures Our management is responsible for
establishing and maintaining adequate internal control over financial reporting.
Our internal control over financial reporting is a process designed to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes of accounting
principles generally accepted in the United States.  Because of its
inherent limitations, internal control over financial reporting may not prevent
or detect misstatements. Therefore, even those systems determined to be
effective can provide only reasonable assurance of achieving their control
objectives. Because of the inherent limitations of internal control, there is a
risk that material misstatements may not be prevented or detected on a timely
basis by internal control over financial reporting.  However, these
inherent limitations are known features of the financial reporting process.
 Therefore, it is possible to design into the process safeguards to reduce,
though not eliminate this risk.  As of March 31, 2009, management assessed
the effectiveness of our internal control over financial reporting.  Based
on that evaluation, they concluded that, during the period covered by this
report, such internal controls and procedures were not effective to detect the
inappropriate application of US GAAP rules.  The determination of
ineffective internal control is based upon the lack of separation of duties. In
evaluating the effectiveness of our internal control over financial reporting,
our management used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in Internal Control 
Integrated Framework.  Under the supervision and with the
participation of our senior management, including our chief executive officer
and chief financial officer, Paul Hunston, we conducted an evaluation of the
effectiveness of the design and operation of our disclosure controls and
procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended (the Exchange Act), as of the end of the
period covered by this quarterly report (the Evaluation Date). Based on this
evaluation, our chief executive officer and chief financial officer concluded as
of the Evaluation Date that our disclosure controls and procedures were not
effective such that the information relating to us required to be disclosed in
our Securities and Exchange Commission (SEC) reports (i) is recorded,
processed, summarized and reported within the time periods specified in SEC
rules and forms, and (ii) is accumulated and communicated to our management,
including our chief executive officer and chief financial officer, as
appropriate to allow timely decisions regarding required disclosure.  Officers Certifications  Appearing as exhibits to this quarterly
report are Certifications of our Chief Executive Officer and Chief Financial
Officer. The Certifications are required pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 (the Section 302 Certifications). This section of
the Quarterly Report contains information concerning the Controls Evaluation
referred to in the Section 302 Certification. This information should be read in
conjunction with the Section 302 Certifications for a more complete
understanding of the topics presented.  Changes in Internal Control Over
Financial Reporting  There have been no changes in our internal
control over financial reporting that occurred during the quarter ended March
31, 2009 that have materially affected or are reasonably likely to materially
affect our internal control over financial reporting.


14


PART
II - OTHER INFORMATION  Item 1. Legal Proceedings.  None  Item 1A. Risk Factors  Not applicable  Item 2. Unregistered Sales of Equity
Securities and Use of Proceeds.  None.  Item 3. Defaults Upon Senior Securities.  None  Item 4. Submission of Matters to a Vote of
Security Holders.  None.  Item 5. Other Information.  None.  Item 6. Exhibits.  The following exhibits are filed
herewith: 3.1 Articles
of Amendment 3.2
Certificate of Correction 31.1
Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities
Exchange Act of 1934, as amended. 32.1
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002.


15


SIGNATURES Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned thereunto duly authorized. FOUNTAIN HEALTHY AGING,
INC. Name

Title

Date***/s/ Paul Hunston***

CEO, CFO, Director

May 29, 2009